Today: 28 June 2026
ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech
23 February 2026
2 mins read

ASX 200 today: Australia shares seen softer after tariff uncertainty jars banks, tech

Sydney, Feb 24, 2026, 04:18 AEDT — Premarket

  • ASX 200 futures suggested a muted open, following Monday’s drop.
  • Tariff jitters hammered risk appetite, leaving banks and growth stocks absorbing most of the blow.
  • Australia’s January inflation figures land Wednesday, and traders are on alert.

Australian shares looked likely to start lower Tuesday, as futures on the main index traded near 8,988—roughly 0.4% under Monday’s closing level. These contracts allow investors to take a view on the index ahead of the session’s open.

The S&P/ASX 200 slipped 55.4 points on Monday, losing 0.61% to finish at 9,026 as U.S. tariff uncertainty weighed on the market. After the U.S. Supreme Court blocked President Donald Trump’s emergency tariffs, Trump pivoted to a 10% global tariff and hinted at a possible 15% rate—though details on timing and coverage stayed murky. “Trump headlines equal volatility,” said Mark Gardener, CEO at MPC markets, but he noted that earnings could provide some support. Indo Premier

This matters right now because Australia’s market remains tilted—on one end, expensive growth stocks; on the other, commodity defensives. With trade policy shifting day by day, investors usually dump risk before sorting through the details, and the ASX stands out as a clear barometer of that impulse.

Resources stocks led gains on Monday as investors shifted into so-called “safe-haven” plays—assets considered more stable when markets get shaky. The Gold Sub-Index jumped 4.1%, outpacing a 1.2% lift for the broader resources index. Growth names didn’t fare well: information technology tumbled 4.5%, healthcare was down 2.4%. Megaport plunged 17.5%, Pro Medicus lost 8.9%, and both WiseTech Global and Technology One shed 5.2%. On the flip side, Reece surged 13.9% after surpassing EBIT forecasts. Nuix soared 15.1%, swinging to a profit. Losses included Austal, which fell 11.0%, and Lendlease, down 7.2%. Market Index

The Australian dollar slipped 0.2% late Monday to roughly 70.68 U.S. cents. Spot gold picked up 1.1%, landing at $5,159 an ounce. Brent crude eased 1.3%, trading at $70.84 a barrel. Bitcoin dropped 3.7%, changing hands at $65,080.

With reporting season in full swing, stocks are bouncing around, particularly when outlooks are vague or cash-flow hopes look shaky. All that turbulence can obscure the index’s broader direction—until one-sided selling hits the usual overowned names and the move gets magnified.

The risk cuts both ways. Should tariff rhetoric shift toward actual policy, or spark retaliatory moves, pressure could linger on banks and high-multiple stocks. And that so-called “safe-haven” move into gold names? It can snap back fast if it morphs into a momentum play.

Tuesday brings focus on whether resources can keep their early gains when the rest of the market gets going, and if tech’s slump drags down other growth areas that managed to stay afloat Monday.

Traders are watching Wednesday for the next big domestic signal, when the Australian Bureau of Statistics will publish January CPI data at 11:30 a.m. AEDT. This inflation print regularly shapes Reserve Bank of Australia policy forecasts.

For now, tariff news and upcoming earnings responses are set to drive market direction.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Hawkish Fed Chairman Warsh Challenges Emerging-Market Bond Rally
    June 28, 2026, 10:48 AM EDT. Federal Reserve Chairman Kevin Warsh's hawkish stance disrupted optimism in emerging-market bonds, which had been buoyed by falling energy prices. Investors had hoped lower energy costs would ease pressure on these bonds, but Warsh's remarks signaled a tougher policy outlook. This raises concerns for emerging markets reliant on stable interest rates to support bond demand. Warsh's comments underscore ongoing uncertainty about U.S. monetary policy tightening and its ripple effects globally, particularly on debt-sensitive economies in developing regions.

Latest articles

Ondas (NASDAQ:ONDS) drops 15% in volatile week after resale filing

Ondas (NASDAQ:ONDS) drops 15% in volatile week after resale filing

28 June 2026
Ondas Inc. (NASDAQ:ONDS) plunged 15.5% last week to $7.83 despite joining the Russell 3000 Index and announcing $40M+ in new defense orders; a June 26 filing registered 3.38M acquisition shares for resale, equal to 0.64% of shares, setting up a key test of real demand versus supply as index-driven volume fades ahead of the July 3 market holiday.
NVDA selloff drags $74 billion equity stake into spotlight

NVDA selloff drags $74 billion equity stake into spotlight

28 June 2026
Nvidia plunged 8.6% last week to $192.53, wiping out about $443 billion in equity value, as chip stocks suffered their worst week since April and Nvidia’s massive equity investment book added new risk to quarterly results; a further drop to $189.23 would mark a 20% slide from its May high.
AAPL volume spikes as QQQ faces memory squeeze risk

AAPL volume spikes as QQQ faces memory squeeze risk

28 June 2026
Apple (AAPL) surged 3.14% Friday on massive volume after a weeklong slide, but still lost $209 billion in value as memory chip price hikes forced iPad and MacBook increases; investors face margin pressure, supply-chain risks, and a short trading week with Apple now trading more on memory costs than iPhone cycles.
GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines
Previous Story

GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop